Surveillance and Security in US Medicine and Equipment Supply Chains.

Publication date: Apr 01, 2024

The COVID-19 pandemic exposed vulnerabilities of the United States’ routine and emergency supply chains of medicines and critical equipment. These vulnerabilities underscore an urgent need to prevent routine and emergency shortages by making drug manufacturing more transparent and by tracking how key supplies get to end users. Near real-time surveillance systems must be developed to monitor fluctuations in supplies of medicines and equipment. Implementation of such systems will require getting key stakeholders (clinicians, administrators, community members, manufacturers, and policy makers) to collaborate.

Concepts Keywords
Clinicians Chains
Covid Covid
Drug Emergency
Pandemic Equipment
Surveillance Exposed
Key
Medicines
Pandemic
Routine
Security
Supplies
Supply
Surveillance
Systems
Vulnerabilities

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH emergency
disease VO manufacturing
disease VO time

Original Article

(Visited 1 times, 1 visits today)